NASDAQ:MBIO | Free Cash Flow | MUSTANG BIO, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.01M
2025-12-31-$1.72M
2025-03-31-$1.39M
2024-12-31-$2M$0.00-$2M
2024-03-31-$5.32M
2023-12-31-$7.25M$30,000.00-$7.28M
2023-03-31-$17.81M$0.00-$17.81M
2022-12-31-$15.29M$95,000.00-$15.38M
2022-03-31-$16.29M$1.33M-$17.62M
2021-12-31-$14.7M$1.38M-$16.08M
2021-03-31-$15.58M$458,000.00-$16.04M
2020-12-31-$9.48M$697,000.00-$10.17M
2020-03-31-$10.15M$526,000.00-$10.68M
2019-12-31-$9.49M$891,000.00-$10.38M
2019-03-31-$6.48M$299,000.00-$6.78M
2018-12-31-$6.52M$304,000.00-$6.83M
2018-03-31-$5.57M$676,000.00-$6.24M
2017-12-31-$5.17M$402,000.00-$5.57M
2017-03-31-$2.04M
2016-12-31-$2.26M
2016-03-31-$581,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$5.26M
2024-12-31-$11.41M$0.00-$11.41M
2023-12-31-$49.48M$64,000.00-$49.54M
2022-12-31-$65.07M$2.71M-$67.78M
2021-12-31-$53.67M$3.99M-$57.65M
2020-12-31-$37.32M$1.93M-$39.24M
2019-12-31-$33.58M$2.35M-$35.93M
2018-12-31-$19.24M$6.87M-$26.11M
2017-12-31-$12.95M$424,000.00-$13.37M
2016-12-31-$4.13M